Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835Open textbooks209Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Kidney, Urology and Women's Health›Anuria

Continue where you left off ()

Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Anuria

Kidney, Urology and Women's Health · NLM MeSH · updated 2026-11-04 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 5 min read

Absence of urine formation.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (995 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

Absence of urine formation. It is usually associated with complete bilateral ureteral (ureter) obstruction, complete lower urinary tract obstruction, or unilateral ureteral obstruction when a solitary kidney is present.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Anurias.

Where it fits in the MeSH classification

Broader topics
Kidney Diseases; Urination Disorders

Related concepts

  • Ureter

Research landscape

PubMed indexes 4,092 records tagged with the MeSH heading “Anuria” (counts retrieved 2026-11-04). 84 of them (2.1%) were published from 2020 onward, and the busiest period so far is through 1999 with 3,526 records.

Reviews account for 155 records (3.8%) and meta-analyses for 2. Randomized controlled trials number 20 (0.5%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 3,526 records; 2000-2009: 247 records; 2010-2019: 235 records; 2020 onward: 84 records3,526through 19992472000-20092352010-2019842020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19993,526
2000-2009247
2010-2019235
2020 onward84
Share of records by publication typeReviews: 3.8 percent; Meta-analyses: 0.0 percent; Randomized controlled trials: 0.5 percentReviews3.8% (155)Meta-analyses0.0% (2)Randomized controlled trials0.5% (20)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 4,092 PubMed records
TypeRecordsShare
Reviews1553.8%
Meta-analyses20.0%
Randomized controlled trials200.5%

Method: PubMed query "Anuria"[MeSH Terms] with publication-type and date filters, retrieved 2026-11-04.

Reading the evidence in kidney, urology and women's health

Kidney, urinary and reproductive health research uses lab markers (such as creatinine), imaging, symptom scores and registry data on pregnancy and birth. Findings about pregnancy are especially sensitive to who was studied and when in pregnancy exposure occurred. Nothing on this page is advice about treatment, fertility or pregnancy; speak to a qualified clinician. Check the population, the outcome measured and whether the study accounted for other health differences between groups.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Influenza-associated thrombotic microangiopathies
Bitzan M, Zieg J
2018Review article
Design not recorded in structured metadata
53cc by
PMID 28884355 · DOI · PMC6153504
Case series: Diquat poisoning with acute kidney failure, myocardial damage, and rhabdomyolysis
Yu G, Wang J, Jian T, Shi L, Zhao L, Li Y, et al.
2022Research article
Design not recorded in structured metadata
38cc by
PMID 36353285 · DOI · PMC9638031
Prevalence, risk factors and severity of symptoms of pelvic organ prolapse among Emirati women
Elbiss HM, Osman N, Hammad FT
2015Research article
Design not recorded in structured metadata
33cc by
PMID 26149171 · DOI · PMC4494174
Predictive value of creatinine-cystatin C ratio for mortality and technique failure in anuric peritoneal dialysis patients
Zhang Z, Zhou T, Zhang M, Cheng S
2025Research article
Design not recorded in structured metadata
3cc by
PMID 39746793 · DOI · PMC11702990

Influenza-associated thrombotic microangiopathies [1]

Review article Bitzan M, Zieg J · · 2018 · cited 53 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Thrombotic microangiopathy (TMA) refers to phenotypically similar disorders, including hemolytic uremic syndromes (HUS) and thrombotic thrombocytopenic purpura (TTP).
Closing excerpt
Further research is warranted targeting the roles of viral neuraminidase, enhanced virus-induced complement activation and/or ADAMTS13 antibodies, and rational treatment approaches.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (254 words)

Thrombotic microangiopathy (TMA) refers to phenotypically similar disorders, including hemolytic uremic syndromes (HUS) and thrombotic thrombocytopenic purpura (TTP). This review explores the role of the influenza virus as trigger of HUS or TTP. We conducted a literature survey in PubMed and Google Scholar using HUS, TTP, TMA, and influenza as keywords, and extracted and analyzed reported epidemiological and clinical data. We identified 25 cases of influenza-associated TMA. Five additional cases were linked to influenza vaccination and analyzed separately. Influenza A was found in 83%, 10 out of 25 during the 2009 A(H1N1) pandemic. Two patients had bona fide TTP with ADAMTS13 activity <10%. Median age was 15 years (range 0.5-68 years), two thirds were male. Oligoanuria was documented in 81% and neurological involvement in 40% of patients. Serum C3 was reduced in 5 out of 14 patients (36%); Coombs test was negative in 7 out of 7 and elevated fibrin/fibrinogen degradation products were documented in 6 out of 8 patients. Pathogenic complement gene mutations were found in 7 out of 8 patients tested (C3, MCP, or MCP combined with CFB or clusterin). Twenty out of 24 patients recovered completely, but 3 died (12%). Ten of the surviving patients underwent plasma exchange (PLEX) therapy, 5 plasma infusions. Influenza-mediated HUS or TTP is rare. A sizable proportion of tested patients demonstrated mutations associated with alternative pathway of complement dysregulation that was uncovered by this infection. Further research is warranted targeting the roles of viral neuraminidase, enhanced virus-induced complement activation and/or ADAMTS13 antibodies, and rational treatment approaches.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 28884355 · DOI · PMC6153504

Case series: Diquat poisoning with acute kidney failure, myocardial damage, and rhabdomyolysis [2]

Research article Yu G, Wang J, Jian T, Shi L, Zhao L, Li Y, et al. · · 2022 · cited 38 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Diquat is a herbicide that can have deleterious effects on the kidneys, liver, heart, lungs, and central nervous system on ingestion.
Closing excerpt
Hemoperfusion and hemofiltration could be effective treatments for eliminating diquat in the blood.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (229 words)

Diquat is a herbicide that can have deleterious effects on the kidneys, liver, heart, lungs, and central nervous system on ingestion. Diquat poisoning-associated rhabdomyolysis has rarely been reported. We describe two cases of diquat poisoning with acute renal failure, myocardial damage, and rhabdomyolysis. Case 1: A 17-year-old man experienced anuria after ingesting ~200 mL of diquat 16 h prior. On admission, his creatinine (400 μmol/L), urea (11.7 mmol/L), creatine kinase (2,534 IU/L), and myohemoglobin (4,425 ng/mL) concentrations were elevated. Case 2: An 18-year-old woman who ingested ~200 mL of diquat 5.5 h prior to admission had normal creatinine, urea, and creatine kinase concentrations. Eleven hours after ingestion, she developed anuria with elevated creatinine (169 μmol/L) concentration; her creatine kinase (13,617 IU/L) and myohemoglobin (>3,811 ng/mL) concentrations were remarkably elevated 24 h after ingestion. Both patients also had elevated aminotransferase and myocardial enzyme concentrations. After undergoing hemoperfusion and hemofiltration, blood diquat concentrations in cases 1 and 2 on admission (16/6 h after ingestion), after hemoperfusion (20/11 h after ingestion), and after 8 h of hemofiltration/8 h of hemofiltration and 2 h of hemoperfusion (29/21 h after ingestion) were 4.9/9.1, 3.4/5.4, and 1.5/1.2 μg/mL, respectively. Severe diquat poisoning can cause acute kidney failure and rhabdomyolysis. Rhabdomyolysis may induce myocardial injury, aggravating kidney damage, and also increase transaminase concentration. Hemoperfusion and hemofiltration could be effective treatments for eliminating diquat in the blood.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 36353285 · DOI · PMC9638031

Prevalence, risk factors and severity of symptoms of pelvic organ prolapse among Emirati women [3]

Research article Elbiss HM, Osman N, Hammad FT · · 2015 · cited 33 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundSimilar to other Gulf countries, the society in United Arab Emirates is pro-natal with high parity and high prevalence of macrosomic babies.
Closing excerpt
Additional healthcare campaigns are required to educate the public regarding these risk factors.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (269 words)

BackgroundSimilar to other Gulf countries, the society in United Arab Emirates is pro-natal with high parity and high prevalence of macrosomic babies. Therefore, it is possible to have a high prevalence of pelvic organ prolapse (POP). Thus, the aim of this study was to determine the prevalence of POP symptoms in one of the UAE cities.MethodsA cross-sectional study of all women who attended the three family development centres was conducted in Al-Ain from January 2010 to January 2011. Non-Emirati, pregnant and nulliparous women younger than 30 years were excluded.ResultsOut of 482 women who met the inclusion criteria, 429 (89.0%) agreed to fully participate in the study. 127 women (29.6%) reported symptoms of POP (mean age: 38.2 years, range: 18-71). Out of the 127 affected women, a dragging lump was felt occasionally in 68%, sometimes in 19%, most of times in 9% and all the times in 4%. 73% of affected women experienced soreness in the vagina. Around one third had to insert their fingers in the vagina to either start or complete emptying of the bladder or to empty the bowel. Using multivariate analysis, the independent risk factors were history of constipation, level of education, chronic chest disease, nature of occupation, birth weight and body mass index (Odds ratio; 95% Confidence interval): (4.1; 2.3-7.3), (1.7; 1.2-2.3), (2.9; 1.6-5.5), (0.5; 0.4-0.8), (1.7; 1.1-2.5), (1.1; 1.0-1.1), respectively (P ConclusionSymptoms of POP are prevalent among Emirati women. Independent risk factors included history of chronic constipation and chest disease, level of education, job type, birth weight and body mass index. Additional healthcare campaigns are required to educate the public regarding these risk factors.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 26149171 · DOI · PMC4494174

Predictive value of creatinine-cystatin C ratio for mortality and technique failure in anuric peritoneal dialysis patients [4]

Research article Zhang Z, Zhou T, Zhang M, Cheng S · · 2025 · cited 3 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
ObjectivesBoth serum creatinine and cystatin C serve as dependable markers of renal function and have demonstrated a correlation with clinical outcomes in diverse conditions, particularly through the ratio of creatinine to cystatin C (Cr/CysC).
Closing excerpt
ConclusionThe Cr/CysC ratio at baseline was recognized as an independent predictor of all-cause mortality and technique failure in anuric PD patients.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (243 words)

ObjectivesBoth serum creatinine and cystatin C serve as dependable markers of renal function and have demonstrated a correlation with clinical outcomes in diverse conditions, particularly through the ratio of creatinine to cystatin C (Cr/CysC). Anuric patients undergoing peritoneal dialysis (PD) depend entirely on the clearance of peritoneal solutes. This research posits that the Cr/CysC ratio may predict all-cause mortality and technique failure in anuric PD patients.MethodsA cohort of 224 anuric PD patients was recruited from January 1, 2014, to December 31, 2019, with follow-up extending until December 31, 2023. The Cr/CysC ratio was computed by dividing the serum creatinine concentration by the cystatin C concentration obtained on the same day. We evaluated the relationship between the Cr/CysC ratio and patient survival, as well as technique failure, utilizing Cox regression and competing risk analyses.ResultsThe average age of the participants was 50.46 ± 12.63 years, with 99 individuals (44.2%) being male. Among all subjects, the Cr/CysC ratio was found to be 1.85 ± 0.56. After controlling for potential confounders, Cox proportional hazards models revealed that the Cr/CysC ratio was significantly linked to the risk of all-cause mortality and technique failure (HR = 0.330, 95% CI 0.124-0.881, p = 0.027; HR = 0.440, 95% CI 0.267-0.726, p = 0.002). Importantly, the significant associations observed in the Cox regression analysis persisted even after accounting for competing risks.ConclusionThe Cr/CysC ratio at baseline was recognized as an independent predictor of all-cause mortality and technique failure in anuric PD patients.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 39746793 · DOI · PMC11702990

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Amnioinfusions to Treat Early Onset Anhydramnios Caused by Renal Anomalies: Background and Rationale for the Renal Anhydramnios Fetal Therapy Trial [5]
    O'Hare EM, Jelin AC, Miller JL, Ruano R, Atkinson MA, Baschat AA, et al. · Fetal Diagn Ther · 2019 · cited 33 times (Europe PMC)
  • Research article Pathogenesis of oliguria in acute renal failure [6]
    Finn WF, Arendshorst WJ, Gottschalk CW · Circ Res · 1975 · cited 28 times (Europe PMC)
  • Research article Continuous arteriovenous hemofiltration in children [7]
    Lieberman KV · Pediatr Nephrol · 1987 · cited 26 times (Europe PMC)
  • Research article Pharmacology and therapeutic use of low-dose dopamine [8]
    Dasta JF, Kirby MG · Pharmacotherapy · 1986 · cited 23 times (Europe PMC)
  • Research article Acute oliguria [9]
    Harrington JT, Cohen JJ · N Engl J Med · 1975 · cited 16 times (Europe PMC)
  • Research article Reflex anuria: an old concept with new evidence [10]
    Hou W, Wen J, Ji Z, Chen J, Li H · Int Urol Nephrol · 2014 · cited 13 times (Europe PMC)

References

  1. Bitzan M, Zieg J. Influenza-associated thrombotic microangiopathies. . 2018. PMID 28884355 · DOI · PMC6153504
  2. Yu G, Wang J, Jian T, Shi L, Zhao L, Li Y, et al.. Case series: Diquat poisoning with acute kidney failure, myocardial damage, and rhabdomyolysis. . 2022. PMID 36353285 · DOI · PMC9638031
  3. Elbiss HM, Osman N, Hammad FT. Prevalence, risk factors and severity of symptoms of pelvic organ prolapse among Emirati women. . 2015. PMID 26149171 · DOI · PMC4494174
  4. Zhang Z, Zhou T, Zhang M, Cheng S. Predictive value of creatinine-cystatin C ratio for mortality and technique failure in anuric peritoneal dialysis patients. . 2025. PMID 39746793 · DOI · PMC11702990
  5. O'Hare EM, Jelin AC, Miller JL, Ruano R, Atkinson MA, Baschat AA, et al.. Amnioinfusions to Treat Early Onset Anhydramnios Caused by Renal Anomalies: Background and Rationale for the Renal Anhydramnios Fetal Therapy Trial. Fetal Diagn Ther. 2019. PMID 30897573 · DOI · PMC8577736
  6. Finn WF, Arendshorst WJ, Gottschalk CW. Pathogenesis of oliguria in acute renal failure. Circ Res. 1975. PMID 1093747 · DOI
  7. Lieberman KV. Continuous arteriovenous hemofiltration in children. Pediatr Nephrol. 1987. PMID 3153297 · DOI
  8. Dasta JF, Kirby MG. Pharmacology and therapeutic use of low-dose dopamine. Pharmacotherapy. 1986. PMID 3547350 · DOI
  9. Harrington JT, Cohen JJ. Acute oliguria. N Engl J Med. 1975. PMID 1088977 · DOI
  10. Hou W, Wen J, Ji Z, Chen J, Li H. Reflex anuria: an old concept with new evidence. Int Urol Nephrol. 2014. PMID 23979816 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-11-04; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-11-04.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • HydronephrosisKidney, Urology and Women's Health
  • Acute Kidney InjuryKidney, Urology and Women's Health
  • Atypical Hemolytic Uremic SyndromeKidney, Urology and Women's Health
  • AzotemiaKidney, Urology and Women's Health
  • EnuresisKidney, Urology and Women's Health
  • GlomerulonephritisKidney, Urology and Women's Health

All 73 articles in Kidney, Urology and Women's Health →

At a glance

4,092
PubMed records on this heading
2%
published since 2020
155
review articles
20
randomized trials
10
verified references below

Counts come from PubMed on 2026-11-04; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • HydronephrosisKidney, Urology and Women's Health
  • Acute Kidney InjuryKidney, Urology and Women's Health
  • Atypical Hemolytic Uremic SyndromeKidney, Urology and Women's Health
  • AzotemiaKidney, Urology and Women's Health
  • EnuresisKidney, Urology and Women's Health

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support